Factors | Number of cases (%) | Local recurrence rate | P |
---|---|---|---|
Gender | 0.671 | ||
Male | 42/146 | 28.8 | |
Female | 29/110 | 26.4 | |
Age | 0.939 | ||
<55 | 20/73 | 27.4 | |
>55 | 51/183 | 27.9 | |
Histological classification | 0.005 | ||
Well differentiation | 6/49 | 12.2 | |
Moderate differentiation | 11/51 | 21.6 | |
Low differentiation (including signet ring cell carcinoma) | 54/156 | 34.6 | |
Vascular tumor emboli | 0.641 | ||
With | 22/85 | 25.9 | |
Without | 49/171 | 28.7 | |
T staging | <0.001 | ||
T1 | 1/7 | 14.3 | |
T2 | 16/102 | 15.7 | |
T3 | 31/112 | 27.7 | |
T4 | 23/35 | 65.9 | |
N staging | 0.022 | ||
N0 | 3/22 | 13.6 | |
N1 | 30/128 | 23.4 | |
N2 | 27/84 | 32.1 | |
N3 | 11/22 | 50.0 | |
TNM clinical staging | 0.014 | ||
Ib | 3/21 | 14.3 | |
II | 16/78 | 20.5 | |
III | 39/131 | 29.8 | |
IV(M0) | 13/26 | 50.0 |